You just read:

Synthetic Biologics Announces Allowance of Key U.S. Patent Covering SYN-010 Intended for the Novel Treatment of Irritable Bowel Syndrome with Constipation (IBS-C)

News provided by

Synthetic Biologics, Inc.

Jun 27, 2017, 07:00 ET